» Articles » PMID: 33101391

FGF2 Affects Parkinson's Disease-Associated Molecular Networks Through Exosomal Rab8b/Rab31

Overview
Journal Front Genet
Date 2020 Oct 26
PMID 33101391
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Ras-associated binding (Rab) proteins are small GTPases that regulate the trafficking of membrane components during endocytosis and exocytosis including the release of extracellular vesicles (EVs). Parkinson's disease (PD) is one of the most prevalent neurodegenerative disorder in the elderly population, where pathological proteins such as alpha-synuclein (α-Syn) are transmitted in EVs from one neuron to another neuron and ultimately across brain regions, thereby facilitating the spreading of pathology. We recently demonstrated fibroblast growth factor-2 (FGF2) to enhance the release of EVs and delineated the proteomic signature of FGF2-triggered EVs in cultured primary hippocampal neurons. Out of 235 significantly upregulated proteins, we found that FGF2 specifically enriched EVs for the two Rab family members and . Consequently, we investigated the interactions of and using a network analysis approach in order to estimate the global influence of their enrichment in EVs. To achieve this, we have demarcated a protein-protein interaction network (PPiN) for these Rabs and identified the proteins associated with PD in various cellular components of the central nervous system (CNS), in different brain regions, and in the enteric nervous system (ENS). A total of 126 direct or indirect interactions were reported for two Rab candidates, out of which 114 are interactions and 54 are interactions, ultimately resulting in an individual interaction score (IS) of 90.48 and 42.86%, respectively. Conclusively, these results for the first time demonstrate the relevance of FGF2-induced Rab-enrichment in EVs and its potential to regulate PD pathophysiology.

Citing Articles

Extracellular vesicles: biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases.

Wang L, Zhang X, Yang Z, Wang B, Gong H, Zhang K Transl Neurodegener. 2024; 13(1):60.

PMID: 39643909 PMC: 11622582. DOI: 10.1186/s40035-024-00453-6.


Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases.

Issa S, Fayoud H, Shaimardanova A, Sufianov A, Sufianova G, Solovyeva V Biomedicines. 2024; 12(8).

PMID: 39200370 PMC: 11351319. DOI: 10.3390/biomedicines12081906.


The Neuromuscular Disorder Mediated by Extracellular Vesicles in Amyotrophic Lateral Sclerosis.

Carata E, Muci M, Di Giulio S, Di Giulio T, Mariano S, Panzarini E Curr Issues Mol Biol. 2024; 46(6):5999-6017.

PMID: 38921029 PMC: 11202069. DOI: 10.3390/cimb46060358.


From Synaptic Physiology to Synaptic Pathology: The Enigma of α-Synuclein.

Nordengen K, Morland C Int J Mol Sci. 2024; 25(2).

PMID: 38256059 PMC: 10815905. DOI: 10.3390/ijms25020986.


The function of previously unappreciated exerkines secreted by muscle in regulation of neurodegenerative diseases.

Bian X, Wang Q, Wang Y, Lou S Front Mol Neurosci. 2024; 16:1305208.

PMID: 38249295 PMC: 10796786. DOI: 10.3389/fnmol.2023.1305208.


References
1.
Dettmer U, Ramalingam N, von Saucken V, Kim T, Newman A, Terry-Kantor E . Loss of native α-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells. Hum Mol Genet. 2017; 26(18):3466-3481. PMC: 5884392. DOI: 10.1093/hmg/ddx227. View

2.
Braak H, Del Tredici K . Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff. J Parkinsons Dis. 2017; 7(s1):S71-S85. PMC: 5345633. DOI: 10.3233/JPD-179001. View

3.
Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T . Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014; 128(6):805-20. DOI: 10.1007/s00401-014-1343-6. View

4.
Braak H, Rub U, Gai W, Del Tredici K . Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna). 2003; 110(5):517-36. DOI: 10.1007/s00702-002-0808-2. View

5.
De Matteis M, Staiano L, Emma F, Devuyst O . The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2. Nat Rev Nephrol. 2017; 13(8):455-470. DOI: 10.1038/nrneph.2017.83. View